JP2023508674A5 - - Google Patents

Info

Publication number
JP2023508674A5
JP2023508674A5 JP2022539134A JP2022539134A JP2023508674A5 JP 2023508674 A5 JP2023508674 A5 JP 2023508674A5 JP 2022539134 A JP2022539134 A JP 2022539134A JP 2022539134 A JP2022539134 A JP 2022539134A JP 2023508674 A5 JP2023508674 A5 JP 2023508674A5
Authority
JP
Japan
Application number
JP2022539134A
Other languages
Japanese (ja)
Other versions
JP2023508674A (ja
JP7702952B2 (ja
JPWO2021130502A5 (https=
Filing date
Publication date
Priority claimed from GBGB1919294.7A external-priority patent/GB201919294D0/en
Application filed filed Critical
Publication of JP2023508674A publication Critical patent/JP2023508674A/ja
Publication of JP2023508674A5 publication Critical patent/JP2023508674A5/ja
Publication of JPWO2021130502A5 publication Critical patent/JPWO2021130502A5/ja
Application granted granted Critical
Publication of JP7702952B2 publication Critical patent/JP7702952B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022539134A 2019-12-24 2020-12-24 Cd163抗体または結合タンパク質 Active JP7702952B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1919294.7 2019-12-24
GBGB1919294.7A GB201919294D0 (en) 2019-12-24 2019-12-24 Antibodies or binding proteins
PCT/GB2020/053370 WO2021130502A1 (en) 2019-12-24 2020-12-24 Cd163 antibodies or binding proteins

Publications (4)

Publication Number Publication Date
JP2023508674A JP2023508674A (ja) 2023-03-03
JP2023508674A5 true JP2023508674A5 (https=) 2023-10-24
JPWO2021130502A5 JPWO2021130502A5 (https=) 2023-10-24
JP7702952B2 JP7702952B2 (ja) 2025-07-04

Family

ID=69322779

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022539134A Active JP7702952B2 (ja) 2019-12-24 2020-12-24 Cd163抗体または結合タンパク質

Country Status (13)

Country Link
US (1) US20230203185A1 (https=)
EP (1) EP4081542A1 (https=)
JP (1) JP7702952B2 (https=)
KR (1) KR20220119147A (https=)
CN (1) CN121873247A (https=)
BR (1) BR112022012362A2 (https=)
CL (1) CL2022001706A1 (https=)
CO (1) CO2022010294A2 (https=)
DO (2) DOP2022000136A (https=)
GB (1) GB201919294D0 (https=)
MX (1) MX2022007957A (https=)
PE (1) PE20230384A1 (https=)
WO (1) WO2021130502A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR129879A1 (es) * 2022-07-08 2024-10-09 Novo Nordisk As Compuestos de isvd altamente potentes capaces de sustituir al fviii(a)
GB202214979D0 (en) * 2022-10-11 2022-11-23 Eco Animal Health Ltd Binding protein
WO2024156888A1 (en) * 2023-01-27 2024-08-02 Vib Vzw Cd163-binding conjugates
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof
CN119569865B (zh) * 2024-12-20 2025-10-10 西北农林科技大学 一种防治猪繁殖与呼吸障碍综合征病毒感染的混合制剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI3331355T3 (fi) * 2015-08-06 2024-06-17 Univ Missouri Sikojen lisääntymishäiriö- ja keuhkotulehdusoireyhtymävirukselle (PRRSV) resistentti sika ja soluja, joilla on muokattuja CD163-geenejä
US11160260B2 (en) * 2018-04-17 2021-11-02 The Curators Of The University Of Missouri Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)

Similar Documents

Publication Publication Date Title
JP2023508674A5 (https=)
CN305799150S (https=)
CN305801427S (https=)
CN305541336S (https=)
CN305543627S (https=)
CN305544553S (https=)
CN305554442S (https=)
CN305555418S (https=)
CN305556311S (https=)
CN305557857S (https=)
CN305559043S (https=)
CN305560072S (https=)
CN305577787S (https=)
CN305581216S (https=)
CN305581324S (https=)
CN305582122S (https=)
CN305589115S (https=)
CN305589705S (https=)
CN305699323S (https=)
CN305703486S (https=)
CN305708229S (https=)
CN305710228S (https=)
CN305710654S (https=)
CN305712760S (https=)
CN305716231S (https=)